Hydrix

An exciting milestone for Hydrix as we continue expanding our presence across sovereign and advanced technology markets. While many know Hydrix for our deep MedTech and mission-critical development capability, we’re also seeing growing momentum across defence and advanced systems engineering. Pleased to share our Hydrix Defence strategic growth presentation with the market today. Looking forward to the journey ahead. https://lnkd.in/gDu9327v #Hydrix #DefenceTechnology #SovereignCapability #MissionCritical #SystemsEngineering #MedTech

Great to host the NIOA team at Hydrix today following the announcement of this exciting partnership. Together, we're proud to be contributing to the development of critical counter-drone capabilities for Australia’s sovereign defence. As Andrew B., Director of Development & Delivery at Hydrix, shared: “This partnership represents an exciting step forward in delivering advanced, mission-ready C-UAS capabilities. We’re proud to be working alongside NIOA to support innovation that strengthens Australia’s defence outcomes.”

Hydrix is pleased to announce a contract with the NIOA Group to help advance Australian counter-UAS Defence capability. Follow this link for more information: https://lnkd.in/gnSkSYNk #DefenceInnovation #AustralianInnovation #SovereignCapability #ASX #DefenceTech #CounterDrone #DroneTech #NIOA #Hydrix

At Hydrix, we design, develop, and deliver advanced cardiac technologies - because heart health isn’t just our work, it’s something we genuinely care about. While innovation drives progress, sometimes the most powerful step is also the simplest. This Heart Week (4–10 May), we’re encouraging everyone to Never Miss a BEAT. Understanding your risk is the first step. Take a moment to act today.  ⏱ Just 3 minutes - that’s all it takes to check your heart age using the Heart Foundation calculator: https://lnkd.in/g3NFrtjR #HeartWeek #HeartFoundation #HeartHealth #Cardiovascular #MedTech #Hydrix

And the winner is… Pulse Tile, taking out the MedTech Ignite Innovation Pitch Challenge last night at ACMD. In front of a packed room of more than 140 people, four strong finalists pitched ideas that showcase the continued momentum in Australian medtech. Congratulations to Pulse Tile and to Elleesha King, CEO and Founder of Pulsatile Innovations. With more than a decade on the frontline as both a paramedic and registered nurse, Elleesha understands exactly where cardiac arrest response breaks down under pressure. Pulse Tile™ is designed for that moment, a pulse-sensing device providing real-time feedback on CPR rate and depth, helping first responders make faster, more confident decisions when it matters most. As sponsors of the prize, we’re looking forward to working with Elleesha and the team, contributing $30,000 in in-kind consulting to support the next stage of development and commercialisation. Thank you also to the other finalists, Akeeko Medical®, IntoxiSense and The Joey, strong ideas, well delivered. And many thanks to the Medical Technology Association of Australia (MTAA), The Aikenhead Centre for Medical Discovery and neo-bionica for bringing the night together, along with Teneille Murray and the judges Mo Dirani, Andrew Batty, Natalie Murphy and Andrew Maxwell. A night of great conversations, tacos, music, and a packed room that didn’t want to leave.

Tonight, four early-stage MedTech companies take the stage at MTAA’s MedTech Ignite Compass Pitch Challenge to present their breakthrough solutions. In addition, three companies will deliver ‘Fast Ideas’ 60-second rapid-fire innovation pitches designed to inspire and showcase cutting-edge MedTech solutions. It promises to be an exciting evening for everyone involved, and we wish all presenters the very best. At Hydrix, we don’t just support innovation, we help companies bring bold technologies into the world. This year, the Hydrix team is ready to support the winning team with in-kind design and engineering development support. Not advice from the sidelines, but practical work across system architecture, usability, electronics, software and the realities of Class II and III development. Stay tuned, highlights and insights to follow tomorrow! Gavin Coote | Peter Riddell | Pauline Newlove | Faiyaz Tambuwala | Andrew B. | Alan Morris | david pritchard | Nilesh Ghatpande | Brenton Finlayson | Crystina Barnes

Hydrix has earned a well-deserved reputation as the partner MedTech startups turn to when getting to market is non-negotiable. We bring a proven, repeatable approach to complex, regulated devices across surgical, cardiovascular, wearables, neuromodulation and robotics, taking programs from concept to commercial reality. Most importantly, our model enables significant development cost advantages, without compromising quality or regulatory rigor. If you’re pitching at Radar Forum and thinking about what comes next, let’s talk. https://www.hydrix.com #MTIRadarForum #startups #innovation #medtech #HealthInnovation #MedtechInnovator #hydrix

If you’re developing or commercialising next-generation cardiac technology, the challenge isn’t the idea, it’s making it work reliably in the real world. Hydrix has spent 15+ years engineering complex cardiovascular systems, including mechanical circulatory support and advanced cardiac platforms, where performance, safety, and regulatory readiness are non-negotiable. We work with teams to turn ambitious concepts into clinically viable systems, from architecture through to verification and transfer to manufacture. At #ACC26, we’re meeting with organisations tackling the hardest problems in cardiac care. If that’s you, let’s talk. https://lnkd.in/gTvSi7qg #acc26 #cardiology #medtech #innovation #TAH #VAD

See you in Portugal for #LSXEurope! I'm looking forward to meeting with European Medtech innovators to discuss device commercialisation - and to compare their approach and ideas vs. the many I met this week at #LSIUSA2026 #hydrix #surgicalrobotics #medtech #MCS #Neuromodulation #medicalimaging

In cardiac device innovation, don’t solve solved problems.  Hydrix gets you to market faster with greater confidence. For over 15 years, Hydrix has partnered with global pioneers to develop advanced cardiac devices, from artificial hearts and VADs to next-generation surgical robotics systems. Many of these programs are now progressing to First-in-Human trials, enabling the next wave of life-saving innovation. Ready to take your cardiac innovation to First-in-Human?  Connect with us at #ACC26 DM Peter R. Lewis #MedTech #cardiology #TAH #VAD #cvSurg #cvImaging #InterventionalCardiology